INS and Hyperglycemia: In particular, a two-week ISCT was generated on 40,000 virtual unique adult and pediatric patients, showing that, in both adult and pediatric populations, the risk of hypo and hyperglycemia using CGM for insulin dosing was equivalent or even lower than that of using SMBG.